Evidence map›Paper›PMID 37920723›Full record

ArticleCell reports. Physical science2023

DNA recognition and induced genome modification by a hydroxymethyl-γ tail-clamp peptide nucleic acid.

Stanley N Oyaghire, Elias Quijano, J Dinithi R Perera, Hanna K Mandl, W Mark Saltzman, Raman Bahal, Peter M Glazer

Open access · goldAbstract read
In one paragraph

Article in Cell reports. Physical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Current issues in molecular biology · 2026
    Article
  4. Systemic in utero gene editing as a treatment for cystic fibrosis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Recent Cutting-Edge Technologies for the Delivery of Peptide Nucleic Acid.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stanley N OyaghireDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Elias QuijanoDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
J Dinithi R PereraDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Hanna K MandlDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.
W Mark SaltzmanDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.
Raman BahalDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
Peter M GlazerDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Yale University · USUniversity of Connecticut · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
Targeting DNA Repair for Cancer Therapy.R35CA197574 · NCI · YALE UNIVERSITY · PI PETER M GLAZER · 2017 to 2026
$8.6M
Nonenzymatic Gene Editing in Treatment of Heredity SpherocytosisR01HL139756 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G, GLAZER, PETER M · 2019 to 2022
$2.4M
Poly(amine-co-ester)s for targeted delivery of gene editing agents to treat cystic fibrosis in animal models: SCGE Disease Models Studies SupplementUH3HL147352 · NHLBI · YALE UNIVERSITY · PI GLAZER, PETER M, SALTZMAN, W. MARK · 2021 to 2022
$2.4M
Developing next generation synthetic nucleic acid analogous for sickle cell disease gene editingR01HL147028 · NHLBI · UNIVERSITY OF CONNECTICUT STORRS · PI BAHAL, RAMAN · 2020 to 2024
$2.0M
PNA Nanoparticles for Gene Editing In VivoU01AI145965 · NIAID · YALE UNIVERSITY · PI GLAZER, PETER M, LY, DANITH H · 2019 to 2022
$1.6M
NCI NIH HHS R35 CA197574NHLBI NIH HHS R01 HL139756NHLBI NIH HHS R01 HL147028NHLBI NIH HHS UH3 HL147352NIAID NIH HHS U01 AI145965NIDDK NIH HHS P30 DK034989NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Peptide nucleic acids (PNAs) can target and stimulate recombination reactions in genomic DNA. We have reported that γPNA oligomers possessing the diethylene glycol γ-substituent show improved efficacy over unmodified PNAs in stimulating recombination-induced gene modification. However, this structural modification poses a challenge because of the inherent racemization risk in

Identifiers

PMID37920723
PMCPMC10621889
OpenAlexW4387747501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.